1.Proteomics Analysis of Heteromorphic Leaves of Populus euphratica Oliv
Ning YUE ; Cai-Xia ZHENG ; Xue BAI ; Jian-Qing HAO ;
China Biotechnology 2006;0(09):-
By exploring the different components of the lysis buffer and optimize the 2-DE conditions,established the best proteomics technical system for Populus euphratica's heteromorphic leaves,while take the heteromorphic leaves in the same blanche as the test materials to find differences between the protein expressions of the leaves.It showed that the lysis solution which containing 2mmol/L thiourea,7mmol/L urea,2% CHAPS,60mmol/L DTT and 0.2% IPG buffer could dissolve the protein better.Through tandem mass spectrum,the results show that heteromorphic leaves are different in photosynthesis and respiration.This research offered valuable informations for understanding the molecular mechanism during leaves development and elucidating the mechanism of the eco-adaptability of Populus euphratica.
2.Expression and clinical significance of survivin in transitional cell carcinoma of bladder
Baiye JIN ; Jindan LUO ; Jun FAN ; Hao PAN ; Dan XIA ; Hainu GAO ; Songliang CAI
Chinese Journal of Urology 2009;30(9):606-608
cuses tumors. Survivin seems to be a promising marker for analyzing clinical stages and predicting the prognosis of TCC.
3.Prenatal diagnosis of prelingual deafness by determination of SLC26A4 gene mutation
Hao HU ; Lingqian WU ; Desheng LIANG ; Yong FENG ; Fang CAI ; Kun XIA ; Qian PAN ; Zhigao LONG ; Heping DAI ; Jiahui XIA
Chinese Journal of Obstetrics and Gynecology 2000;0(09):-
G mutation of SLC26A4, the parents and the second child were carriers of the same mutation, while the fetus had a wild-type form. Conclusion It is feasible to identify deafness related genes by screening for GJB2 and SLC26A4 mutation, thus providing correct prenatal diagnosis and avoiding deaf delivery of baby.
4.Progress in study of selective ERβ ligands.
Jin-ya CAI ; Jun-hao LI ; Shi-hui DING ; Juan ZHANG ; Gui-xia LIU ; Wei-hua LI ; Yun TANG
Acta Pharmaceutica Sinica 2015;50(6):658-667
Estrogen receptors (ERs) are members of nuclear receptors and related to several diseases such as cancer, inflammation and osteoporosis. ERs have two forms, ERα and ERβ, which have different functions and organism distributions. Compounds selectively targeting ERβ can regulate important physiological functions and avoid the side effects caused by targeting ERα. Therefore, selective ERβ ligands have received considerable research interest in recent years. In this article, different kinds of selective ERβ ligands were summarized and their structure-activity relationships were also analyzed.
Estrogen Receptor beta
;
chemistry
;
Humans
;
Ligands
;
Structure-Activity Relationship
5.The analysis of IL-10 and its methylation in the patients with acute on chronic liver failure
Zhao-Xia QI ; Shu-Xia YU ; Hong-Sheng HAO ; Feng-Cai LI ; Zhao-Yang GUO ; Yu-Chen FAN ; Kai WANG
Chinese Journal of Experimental and Clinical Virology 2011;25(2):99-101
Objective To investigate the effect of IL-10 and the methylation of its promoter in acute on chronic liver failure (ACLF). Methods Patients were divided into three groups: 25 with ACLF, 25 with CHB, 10 healthy controls. Respectively detect the serum level of IL-10 via ELISA, and the methylation of 1L-10 promoter via MSP,to analyze the difference among the three groups. Results Both the ACLF group and the CHB group have significant increase in serum level of IL-10 compared with the control group ( P <0.05 ) ; the ACLF group's level is higher than the CHB group, however without statistical significance (P >0.05 ). The serum level of IL-10 in ACLF group has no significant relativity with ALT and HBV-DNA( r = -0. 022, r = 0. 033, respectively; P > 0. 05 ) ; has positive relativity with TBIL and MELD ( r = 0. 566, r =0.443, respectively; P < 0.05); and negative relativity with PTA (r = - 0.581, P < 0.05). The distribution of the methylation of IL-10 promoter in ACLF group is significantly different from the other two.Conclusion The serum level of IL-10 in hepatitis patients is significantly higher and increases with the degree of liver failure. The promoter methylation may be important in the gene inactivation.
6.Effect of high myopia on 24-hour intraocular pressure in patients with primary open-angle glaucoma.
Ying-xin YANG ; Ning-li WANG ; Lie WU ; Yi ZHEN ; Tao WANG ; Cai-xia REN ; Xiao-xia PENG ; Jie HAO ; Yan-ting XIA
Chinese Medical Journal 2012;125(7):1282-1286
BACKGROUNDAs intraocular pressure (IOP) and IOP fluctuation are known risk factors for glaucoma, it is important to understand the effects of high myopia on these ocular parameters. The aim of this study was to investigate if primary open-angle glaucoma (POAG) patients with high myopia exhibit higher IOP and greater IOP fluctuations at resting conditions over 24 hours.
METHODSWe designed a prospective control clinical study. Eighty-two eyes of 82 high-tension Chinese POAG patients only on prostaglandin analogue locally were divided into 3 groups according to various myopic grades (< -6.0 D, n = 27 and between -0.76 and -5.99 D, n = 33) or without myopia (-0.75 to 0.75 D, n = 22). Single time IOP at 10 am, mean corrected 24-hour IOP, mean corrected night IOP, 24-hour IOP fluctuation and IOPs of 10 am, 2 pm, 6 pm, 10 pm, 2 am, 6 am and 8 am were measured.
RESULTSThe IOP was higher in POAG patients with high myopia over those POAG alone in three ways: the elevated IOP value was 0.65 mmHg measured in single time IOP at 10 am, 0.84 mmHg in mean corrected 24-hour IOP, 0.97 mmHg in mean corrected night IOP. The 24-hour IOP fluctuation was lower in the two myopia groups than in non-myopia group. Further, using repeated measurement analysis of variance, there was no statistical significance among groups regarding the IOPs at the seven time points (P = 0.77) and there was no interaction between groups and time points (P = 0.71), but the difference of IOPs at the seven time points in same group was statistically significant (P = 0.01).
CONCLUSIONHigh-tension POAG patients with high myopia, even on pharmacological glaucoma therapy, still have higher IOP, but 24-hour IOP fluctuation at resting conditions was lower in these patients.
Adolescent ; Adult ; Aged ; Female ; Glaucoma, Open-Angle ; physiopathology ; Humans ; Intraocular Pressure ; physiology ; Male ; Middle Aged ; Myopia ; physiopathology ; Young Adult
7.ICAM-1 expression of rat brain microvascular endothelial cells caused by fluid shear force
Xiao-Yan SONG ; Yan-Jun ZENG ; Cai-Xia LI ; Dong-Hua LIAO ; Jin-Lin HU ; Yan-Lei HAO
Acta Physiologica Sinica 2001;53(1):13-17
We studied the effect of shear stress (SS) on intercellular adhesion molecule-1 (ICAM-1) expression of rat brain microvascular endothelial cells (RBMECs) using the parallel plate flow chamber method. It was demonstrated that RBMECs showed a time-dependent, but not a force-dependent, upregulation in ICAM-1 expression. Endothelial cell surface expression of ICAM-1 in the supernatants of RBMECs exposed to SS was not changed, thus excluding the possibility that the upregulated expression is due to the factors synthesized by these cells. These data throw light on understanding the signal transduction pathway inside the endothelial cells under the effect of SS.
8.Influence of Wenshen Zhixie Fang Administrated through Bellybutton on 5-HT and NO of Spleen and Kidney Yang Deficiency Type IBS-D Patients
Qing-Wei ZHANG ; Hao MENG ; Yin TANG ; Li-Xia CAI ; Xiang LI ; Na LI
Journal of Nanjing University of Traditional Chinese Medicine 2016;32(3):217-219
ABSTRACT:OBJECTIVE To investigate the effects of Whenshen Zhixie Fang administrated through bellybutton and the in-fluence on 5-HT and NO of spleen and kidney yang deficiency type IBS-D patients.METHODS By using computer,parallel group and non-blinded trials,patients were randomly divided into two groups.58 cases in the treatment group were given Wen-shen Zhixie Fang administrated through bellybutton together with orally taken Montmorillonite powder.The control group was given orally taken Montmorillonite powder only.The treating effects were assessed after ten days.RESULTS Total effective rate of the treatment group was 82.76%,which was better than that of the control group (66.10%)(P <0.05).Abdominal pain and discomfort were significantly relieved in the treatment group,and the shape of the stool and frequency were also changed for better(P <0.01),which were better than those of the control group except the stool.And 5-HT was significantly decreased and NO was increased,which were better than those of the control group(P < 0.01).CONCLUSION Wenshen Zhixie Fang administered through Bellybutton can improve the clinical symptoms of IBS-D and its mechanism may be related to the regulation of 5-HT and NO levels and reduction of intestinal sensitivity.
9.Molecular analysis of SLC26A4 gene in a Chinese deafness family.
Hao HU ; De-sheng LIANG ; Ling-qian WU ; Yong FENG ; Fang CAI ; Kun XIA ; Qian PAN ; Zhi-gao LONG ; He-ping DAI ; Jia-hui XIA
Chinese Journal of Medical Genetics 2005;22(4):376-379
OBJECTIVETo identify the pathogenic gene for a non-syndromic hearing loss family.
METHODSMutation analysis was carried out by polymerase chain reaction and direct sequencing of all exons of SLC26A4 (solute carrier family 26, member 4) gene.
RESULTSCompound heterozygous mutations N392Y and S448X were detected in the proband of the family, heterozygous mutation S448X was detected in the father, heterozygous mutation N392Y was detected in the mother.
CONCLUSIONThe proband's hearing loss resulted from the compound heterozygous mutations N392Y and S448X for SLC26A4 gene.
Adult ; Base Sequence ; DNA Mutational Analysis ; Deafness ; diagnostic imaging ; genetics ; pathology ; Family Health ; Female ; Humans ; Male ; Membrane Transport Proteins ; genetics ; Molecular Sequence Data ; Mutation ; Polymerase Chain Reaction ; Tomography, X-Ray Computed
10.Long-term outcomes of gemcitabine and cisplatin in patients with recurrent or metastatic esophageal squamous cell carcinoma: a phase II trial.
Jing HUANG ; Qing-Xia FAN ; Li CHEN ; Ai-Na LIU ; Rui-Gang CAI ; Xue-Zhi HAO ; Jin-Wan WANG ; Yan SUN
Chinese Medical Journal 2011;124(23):4012-4017
BACKGROUNDEsophageal cancer is the sixth most common cause of cancer-related death worldwide. Prior studies had demonstrated potential synergistic antitumor activity of gemcitabine in combination with cisplatin. Therefore, we studied the efficacy and tolerability of such combination for esophageal cancer.
METHODSBetween October 2003 and October 2006, thirty-eight patients with metastatic or recurrent advanced squamous cell carcinoma of the esophagus were enrolled. The median number of treatment cycles per patient was 4 (range 1 - 7). Gemcitabine was given at 1000 mg/m(2) over 30 minutes on days 1, 8 and cisplatin 40 mg/m2 was given on days 1, 2 in an every 21-day cycle.
RESULTSThe median follow-up for all 38 patients was 76 months (range 11 - 88 months). The overall response rate was 42.1% (95%CI, 25.5% - 56.5%). Median progression-free survival and median survival for all patients were 4.1 months (95%CI, 3.0 - 5.7 months) and 10 months (95%CI, 7 - 12 months), respectively. Patients with a response had significantly longer median survival compared with the patients without a response (11 months vs. 7.5 months, P = 0.0069). Overall survival at 1 year was 36.8%, at 2 years was 10.5%, and at 5 years was 5.3%. The most common grade 3 - 4 toxicity for all patients was leucopenia (44.7%).
CONCLUSIONSThis cisplatin-gemcitabine regimen was manageable and had significant efficacy in patients with esophageal squamous cell carcinoma. Patients with a response had improved survival time. Furthermore, a small number of the patients with metastatic esophageal cancer were still alive in 5 years with this regimen.
Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols ; Carcinoma, Squamous Cell ; drug therapy ; mortality ; Cisplatin ; therapeutic use ; Deoxycytidine ; analogs & derivatives ; therapeutic use ; Disease-Free Survival ; Esophageal Neoplasms ; drug therapy ; mortality ; Female ; Humans ; Male ; Middle Aged